Platinum Investment Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $2.09M | Sell |
|
|||||
|
2024
Q4 | $4.96M | Buy |
|
|||||
|
2024
Q3 | $1.23M | Sell |
|
|||||
|
2024
Q2 | $2.97M | Sell |
|
|||||
|
2024
Q1 | $18M | Sell |
|
|||||
|
2023
Q4 | $22.4M | Sell |
|
|||||
|
2023
Q3 | $17.9M | Sell |
|
|||||
|
2023
Q2 | $20.3M | Sell |
|
|||||
|
2023
Q1 | $18.5M | Buy |
|
|||||
|
2022
Q4 | $20.9M | Buy |
|
|||||
|
2022
Q3 | $24M | Sell |
|
|||||
|
2022
Q2 | $20.6M | Buy |
|
|||||
|
2022
Q1 | $15.3M | Buy |
|
|||||
|
2021
Q4 | $24.7M | Buy |
|
|||||
|
2021
Q3 | $15.2M | Buy |
|
|||||
|
2021
Q2 | $17.2M | Buy |
|